While the concept of GLP-1 microdosing is still being explored, the mechanism of GLP-1 drugs suggests how this dosing strategy might address common metabolic issues, and improve: Weight management and appetite control Energy consistency and fatigue reduction Insulin sensitivity While there are no primary clinical trials specifically designed to prove the long-term effectiveness of GLP-1 medication microdosing, the efficacy of low doses has been demonstrated within the full clinical trial data on dose-response relationships and titration phases: A years-long study of 2,405 patients that helped establish the efficacy of the current highest approved dose of semaglutide for weight loss found that lower doses still showed significant weight loss and appetite suppression compared to placebo
A compound pharmacy will also help patients determine whether theyre eligible for semaglutide based on a full review of medical history, lifestyle, and weight-related health markers
Many companies use synthetic fillers, artificial flavors, or low-quality sourcing to keep costs down
Pu J, Zhang J
The most likely cause is telogen effluvium
However, the specific dosage and frequency may vary depending on individual factors such as weight loss goals, response to treatment and recommendations
